Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice
- 15 June 2006
- journal article
- clinical trial
- Published by The American Association of Immunologists
- Vol. 176 (12), 7761-7767
- https://doi.org/10.4049/jimmunol.176.12.7761
Abstract
Several reports have suggested that mesenchymal stem cells (MSCs) could exert a potent immunosuppressive effect in vitro, and thus may have a therapeutic potential for T cell-dependent pathologies. We aimed to establish whether MSCs could be used to control graft-vs-host disease (GVHD), a major cause of morbidity and mortality after allogeneic hemopoietic stem cell transplantation. From C57BL/6 and BALB/c mouse bone marrow cells, we purified and expanded MSCs characterized by the lack of expression of CD45 and CD11b molecules, their typical spindle-shaped morphology, together with their ability to differentiate into osteogenic, chondrogenic, and adipogenic cells. These MSCs suppressed alloantigen-induced T cell proliferation in vitro in a dose-dependent manner, independently of their MHC haplotype. However, when MSCs were added to a bone marrow transplant at a MSCs:T cells ratio that provided a strong inhibition of the allogeneic responses in vitro, they yielded no clinical benefit on the incidence or severity of GVHD. The absence of clinical effect was not due to MSC rejection because they still could be detected in grafted animals, but rather to an absence of suppressive effect on donor T cell division in vivo. Thus, in these murine models, experimental data do not support a significant immunosuppressive effect of MSCs in vivo for the treatment of GVHD.Keywords
This publication has 34 references indexed in Scilit:
- Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient miceBlood, 2005
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyPublished by American Society of Hematology ,2005
- Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen‐induced arthritisArthritis & Rheumatism, 2005
- Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potentialBlood, 2004
- Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)Bone Marrow Transplantation, 2002
- Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman–Diamond syndromeBone Marrow Transplantation, 2002
- Mesenchymal stem cells: heading into the clinicBone Marrow Transplantation, 2001
- Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.JCI Insight, 1998
- Hormones that Stimulate the Growth of Blood CellsScientific American, 1988